148 results found for: Bayer

European Regulators Approve Bayer’s Purchase Of GMO & Pesticide Goliath Monsanto

Two years after pharma company Bayer first agreed to purchase GMO and pesticide Goliath Monsanto, European regulators have given their seal of approval to the deal. […]

Bayer’s takeover of Monsanto reportedly gets clearance in the United States

NEWS The Wall Street Journal reports that the U.S. Department of Justice has decided to approve Bayer’s $66-billion takeover of Monsanto, thus removing the last major […]

Bayer Faces New Trial Over Allegations Glyphosate Weed Killer Causes Cancer

NEWS Bayer is facing a second U.S. jury over allegations that its glyphosate-based weed killer Roundup causes cancer. The trial follows only six months after the […]

Amid Mounting Lawsuits, Bayer Boss Still Claims Monsanto Takeover Was ‘Good Idea’

NEWS With Bayer now facing over 11 thousand lawsuits in the United States over the weed killer Roundup and its active ingredient glyphosate, Bayer boss Werner […]

Bayer And Janssen Agree To $775 Million Settlement Over Blood Thinning Drug Lawsuits

NEWS Bayer and Janssen, the pharmaceutical companies behind the blood thinner Xarelto, have reached a $775 million settlement in 25 thousand lawsuits alleging patients were not […]

Beware Of The Bitten Dog: How Bayer’s Desperate Situation Could Lead To Desperate Acts

The Monsanto takeover in 2018 promised big business for Bayer. At a time of intense pressure on pharmaceutical companies, the strengthening of Bayer’s agrichemical division seemed […]

Bayer Tries To Counter Mounting Toxicity Concerns About Monsanto Weed Killer

NEWS Drug company Bayer, which bought Monsanto last summer, says it is making scientific studies available for public scrutiny. It is trying to counter growing concerns about […]

Three Strikes And You’re Out: Time To Bring An End To Bayer Putting Profit Over Life

On Thursday 4 April 2019, our Foundation published an article describing how, due to the growing problems following Bayer’s takeover of Monsanto, the company’s situation could […]